25 XP   0   0   10

Erasca Inc
Buy, Hold or Sell?

Let's analyse Erasca together

PenkeI guess you are interested in Erasca Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Erasca Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Erasca Inc

I send you an email if I find something interesting about Erasca Inc.

Quick analysis of Erasca (30 sec.)










What can you expect buying and holding a share of Erasca? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.10
Expected worth in 1 year
$1.47
How sure are you?
15.4%

+ What do you gain per year?

Total Gains per Share
$-0.63
Return On Investment
-33.5%

For what price can you sell your share?

Current Price per Share
$1.88
Expected price per share
$1.64 - $2.45
How sure are you?
50%

1. Valuation of Erasca (5 min.)




Live pricePrice per Share (EOD)

$1.88

Intrinsic Value Per Share

$-3.12 - $-3.43

Total Value Per Share

$-1.03 - $-1.33

2. Growth of Erasca (5 min.)




Is Erasca growing?

Current yearPrevious yearGrowGrow %
How rich?$316.6m$399.2m-$48m-13.7%

How much money is Erasca making?

Current yearPrevious yearGrowGrow %
Making money-$30.3m-$59.6m$29.3m96.8%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Erasca (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#172 / 1010

Most Revenue
#947 / 1010

Most Profit
#798 / 1010

Most Efficient
#389 / 1010

What can you expect buying and holding a share of Erasca? (5 min.)

Welcome investor! Erasca's management wants to use your money to grow the business. In return you get a share of Erasca.

What can you expect buying and holding a share of Erasca?

First you should know what it really means to hold a share of Erasca. And how you can make/lose money.

Speculation

The Price per Share of Erasca is $1.88. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Erasca.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Erasca, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.10. Based on the TTM, the Book Value Change Per Share is $-0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Erasca.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.20-10.5%-0.21-11.0%-0.40-21.4%-0.28-15.0%-0.28-15.0%
Usd Book Value Change Per Share-0.15-7.8%-0.16-8.4%-0.07-3.9%0.168.6%0.168.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.15-7.8%-0.16-8.4%-0.07-3.9%0.168.6%0.168.6%
Usd Price Per Share2.13-2.47-6.57-5.61-5.61-
Price to Earnings Ratio-2.71--2.97--6.08--5.61--5.61-
Price-to-Total Gains Ratio-14.44--15.61--23.71--24.12--24.12-
Price to Book Ratio1.02-1.06-2.50-2.00-2.00-
Price-to-Total Gains Ratio-14.44--15.61--23.71--24.12--24.12-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.88
Number of shares531
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.160.16
Usd Total Gains Per Share-0.160.16
Gains per Quarter (531 shares)-83.6285.62
Gains per Year (531 shares)-334.47342.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-334-3440342332
20-669-6780685674
30-1003-1012010271016
40-1338-1346013701358
50-1672-1680017121700
60-2007-2014020552042
70-2341-2348023972384
80-2676-2682027402726
90-3010-3016030823068
100-3345-3350034253410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%2.011.00.015.4%2.011.00.015.4%2.011.00.015.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%2.011.00.015.4%2.011.00.015.4%2.011.00.015.4%

Fundamentals of Erasca

About Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-11 07:03:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Erasca Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Erasca earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Erasca to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Erasca Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Erasca is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Erasca to the Biotechnology industry mean.
  • -7.5% Return on Assets means that Erasca generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Erasca Inc:

  • The MRQ is -7.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.5%TTM-7.1%-0.5%
TTM-7.1%YOY-12.3%+5.2%
TTM-7.1%5Y-12.6%+5.5%
5Y-12.6%10Y-12.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.5%-13.3%+5.8%
TTM-7.1%-12.8%+5.7%
YOY-12.3%-11.7%-0.6%
5Y-12.6%-13.9%+1.3%
10Y-12.6%-15.7%+3.1%
1.1.3. Return on Equity

Shows how efficient Erasca is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Erasca to the Biotechnology industry mean.
  • -9.4% Return on Equity means Erasca generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Erasca Inc:

  • The MRQ is -9.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-4.5%-4.8%
TTM-4.5%YOY-4.4%-0.2%
TTM-4.5%5Y-4.0%-0.5%
5Y-4.0%10Y-4.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.4%-16.9%+7.5%
TTM-4.5%-16.1%+11.6%
YOY-4.4%-15.1%+10.7%
5Y-4.0%-19.3%+15.3%
10Y-4.0%-20.2%+16.2%

1.2. Operating Efficiency of Erasca Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Erasca is operating .

  • Measures how much profit Erasca makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Erasca to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Erasca Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient Erasca is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Erasca Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y-7.876-7.876

1.3. Liquidity of Erasca Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Erasca is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 12.26 means the company has $12.26 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Erasca Inc:

  • The MRQ is 12.260. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.300. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.260TTM13.300-1.040
TTM13.300YOY14.572-1.273
TTM13.3005Y14.726-1.426
5Y14.72610Y14.7260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.2603.890+8.370
TTM13.3004.173+9.127
YOY14.5725.344+9.228
5Y14.7266.126+8.600
10Y14.7266.448+8.278
1.3.2. Quick Ratio

Measures if Erasca is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Erasca to the Biotechnology industry mean.
  • A Quick Ratio of 20.33 means the company can pay off $20.33 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Erasca Inc:

  • The MRQ is 20.325. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 20.330. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ20.325TTM20.330-0.005
TTM20.330YOY17.815+2.515
TTM20.3305Y19.011+1.319
5Y19.01110Y19.0110.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.3253.514+16.811
TTM20.3303.998+16.332
YOY17.8155.380+12.435
5Y19.0116.105+12.906
10Y19.0116.404+12.607

1.4. Solvency of Erasca Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Erasca assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Erasca to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.20 means that Erasca assets are financed with 19.9% credit (debt) and the remaining percentage (100% - 19.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Erasca Inc:

  • The MRQ is 0.199. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.185. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.199TTM0.185+0.014
TTM0.185YOY0.150+0.035
TTM0.1855Y0.516-0.331
5Y0.51610Y0.5160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1990.339-0.140
TTM0.1850.336-0.151
YOY0.1500.271-0.121
5Y0.5160.366+0.150
10Y0.5160.389+0.127
1.4.2. Debt to Equity Ratio

Measures if Erasca is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Erasca to the Biotechnology industry mean.
  • A Debt to Equity ratio of 24.8% means that company has $0.25 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Erasca Inc:

  • The MRQ is 0.248. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.116. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.248TTM0.116+0.132
TTM0.116YOY0.061+0.054
TTM0.1165Y0.068+0.048
5Y0.06810Y0.0680.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2480.388-0.140
TTM0.1160.402-0.286
YOY0.0610.335-0.274
5Y0.0680.426-0.358
10Y0.0680.461-0.393

2. Market Valuation of Erasca Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Erasca generates.

  • Above 15 is considered overpriced but always compare Erasca to the Biotechnology industry mean.
  • A PE ratio of -2.71 means the investor is paying $-2.71 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Erasca Inc:

  • The EOD is -2.391. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.709. Based on the earnings, the company is expensive. -2
  • The TTM is -2.966. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.391MRQ-2.709+0.318
MRQ-2.709TTM-2.966+0.257
TTM-2.966YOY-6.081+3.115
TTM-2.9665Y-5.608+2.642
5Y-5.60810Y-5.6080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.391-2.264-0.127
MRQ-2.709-2.629-0.080
TTM-2.966-2.680-0.286
YOY-6.081-4.145-1.936
5Y-5.608-6.257+0.649
10Y-5.608-6.254+0.646
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Erasca Inc:

  • The EOD is -2.855. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.235. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.165. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.855MRQ-3.235+0.380
MRQ-3.235TTM-3.165-0.070
TTM-3.165YOY-8.326+5.161
TTM-3.1655Y-7.219+4.055
5Y-7.21910Y-7.2190.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.855-2.973+0.118
MRQ-3.235-3.333+0.098
TTM-3.165-3.553+0.388
YOY-8.326-5.605-2.721
5Y-7.219-8.376+1.157
10Y-7.219-8.865+1.646
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Erasca is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.02 means the investor is paying $1.02 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Erasca Inc:

  • The EOD is 0.897. Based on the equity, the company is cheap. +2
  • The MRQ is 1.016. Based on the equity, the company is underpriced. +1
  • The TTM is 1.055. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.897MRQ1.016-0.119
MRQ1.016TTM1.055-0.039
TTM1.055YOY2.499-1.444
TTM1.0555Y2.001-0.946
5Y2.00110Y2.0010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8971.896-0.999
MRQ1.0162.115-1.099
TTM1.0552.093-1.038
YOY2.4992.884-0.385
5Y2.0013.542-1.541
10Y2.0013.916-1.915
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Erasca Inc.

3.1. Institutions holding Erasca Inc

Institutions are holding 54.766% of the shares of Erasca Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31ARCH VENTURE CORP7.317314.4021105555400
2023-12-31Armistice Capital, LLC5.35850.23548096000-260000-3.1115
2023-12-31BlackRock Inc4.83850.000473103212830784.0283
2023-12-31Artal Group S A3.12480.3343472119400
2023-09-30Partner Fund Management LP2.60160.36483930633-866827-18.0685
2023-12-31Vanguard Group Inc2.510.00023792343-1322769-25.86
2023-12-31Goldman Sachs Group Inc1.71690.000525940841930234290.7636
2023-12-31Renaissance Technologies Corp1.32940.006620085001266400170.6509
2023-09-30International Biotechnology Trust PLC1.27481.2782192600050000035.0631
2023-12-31Schroder Investment Management Group1.27480.0053192600019260000
2023-12-31Geode Capital Management, LLC1.19920.00041811911965185.6266
2023-09-30Citadel Advisors Llc1.16660.0007176264546581335.9193
2023-12-31State Street Corporation1.10220.0002166530417023911.3867
2023-12-31Millennium Management LLC0.98260.001414846081068501256.7852
2023-12-31Nuveen Asset Management, LLC0.79420.0008119995220120.168
2023-12-31Two Sigma Investments LLC0.66020.0049997419563282129.7475
2023-12-31Woodline Partners LP0.60830.0213919119795546643.7863
2023-12-31EDBI Pte Ltd0.58831.873388888800
2023-12-31Bank of America Corp0.4810.000272675118643534.5048
2023-12-31Northern Trust Corp0.46390.0003700917-17188-2.3935
Total 39.393118.531259518143+6787274+11.4%

3.2. Funds holding Erasca Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.5670.0004237387900
2024-03-28iShares Russell 2000 ETF1.33050.006320155949720.0482
2024-01-31International Biotechnology Ord1.27130.9709192600000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.77920.00281180377169131.4537
2024-01-31Fidelity Small Cap Index0.53250.005480665246300.5773
2024-03-28iShares Russell 2000 Value ETF0.50690.0126767951-487-0.0634
2024-03-28iShares Biotechnology ETF0.43770.017966316200
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.33710.002951071200
2024-02-29Fidelity Extended Market Index0.30890.0029467999-2268-0.4823
2024-03-29Schwab US Small-Cap ETF™0.26220.004839714800
2024-01-31CREF Stock R10.22090.0005334590-245190-42.2902
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.20250.006530671800
2024-02-29Vanguard Russell 2000 ETF0.19620.0074297174230418.405
2024-02-29Vanguard Health Care ETF0.170.002925746813120.5122
2023-12-31NT R2000 Value Index Fund - NL0.14610.0125221287-5709-2.515
2023-12-31NT R2000 Index Fund - NL0.1450.0065219718-5373-2.387
2024-03-28iShares Core S&P Total US Stock Mkt ETF0.13590.0008205919-154-0.0747
2023-09-30BlackRock Extended Mkt Composite0.13050.002819772514120.7193
2024-01-31TIAA-CREF Equity Index Instl0.12840.000819448400
2024-02-29Schwab Small Cap Index0.12180.007418446800
Total 8.93061.07513529025-210901-1.6%

3.3. Insider Transactions

Insiders are holding 23.33% of the shares of Erasca Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-06Valerie Denise Harding StartBUY100001.85
2023-12-05Jonathan E LimBUY7218501.69
2023-12-04Alexander W CasdinBUY300001.66
2023-10-05Jonathan E LimBUY10000002.03
2023-06-08Jonathan E LimBUY1000002.75
2023-04-10Alexander W CasdinBUY200002.76

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Erasca Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.148-0.157+7%-0.074-50%0.161-191%0.161-191%
Book Value Per Share--2.0962.325-10%2.642-21%1.806+16%1.806+16%
Current Ratio--12.26013.300-8%14.572-16%14.726-17%14.726-17%
Debt To Asset Ratio--0.1990.185+7%0.150+32%0.516-61%0.516-61%
Debt To Equity Ratio--0.2480.116+114%0.061+304%0.068+264%0.068+264%
Dividend Per Share----0%-0%-0%-0%
Eps---0.197-0.207+5%-0.402+104%-0.281+43%-0.281+43%
Free Cash Flow Per Share---0.165-0.204+24%-0.198+20%-0.191+16%-0.191+16%
Free Cash Flow To Equity Per Share---0.162-0.201+25%-0.036-78%0.084-293%0.084-293%
Gross Profit Margin--0.9680.992-2%1.000-3%0.998-3%0.998-3%
Intrinsic Value_10Y_max---3.431--------
Intrinsic Value_10Y_min---3.122--------
Intrinsic Value_1Y_max---0.695--------
Intrinsic Value_1Y_min---0.683--------
Intrinsic Value_3Y_max---1.820--------
Intrinsic Value_3Y_min---1.743--------
Intrinsic Value_5Y_max---2.623--------
Intrinsic Value_5Y_min---2.457--------
Market Cap284043575.040-13%321815327.040372807192.240-14%992641642.560-68%847830556.431-62%847830556.431-62%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.897-13%1.0161.055-4%2.499-59%2.001-49%2.001-49%
Pe Ratio-2.391+12%-2.709-2.966+9%-6.081+124%-5.608+107%-5.608+107%
Price Per Share1.880-13%2.1302.468-14%6.570-68%5.612-62%5.612-62%
Price To Free Cash Flow Ratio-2.855+12%-3.235-3.165-2%-8.326+157%-7.219+123%-7.219+123%
Price To Total Gains Ratio-12.744+12%-14.438-15.611+8%-23.708+64%-24.116+67%-24.116+67%
Quick Ratio--20.32520.3300%17.815+14%19.011+7%19.011+7%
Return On Assets---0.075-0.071-6%-0.123+63%-0.126+67%-0.126+67%
Return On Equity---0.094-0.045-52%-0.044-53%-0.040-57%-0.040-57%
Total Gains Per Share---0.148-0.157+7%-0.074-50%0.161-191%0.161-191%
Usd Book Value--316686000.000351204500.000-10%399225250.000-21%272922923.077+16%272922923.077+16%
Usd Book Value Change Per Share---0.148-0.157+7%-0.074-50%0.161-191%0.161-191%
Usd Book Value Per Share--2.0962.325-10%2.642-21%1.806+16%1.806+16%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.197-0.207+5%-0.402+104%-0.281+43%-0.281+43%
Usd Free Cash Flow---24870000.000-30748000.000+24%-29953750.000+20%-28800923.077+16%-28800923.077+16%
Usd Free Cash Flow Per Share---0.165-0.204+24%-0.198+20%-0.191+16%-0.191+16%
Usd Free Cash Flow To Equity Per Share---0.162-0.201+25%-0.036-78%0.084-293%0.084-293%
Usd Market Cap284043575.040-13%321815327.040372807192.240-14%992641642.560-68%847830556.431-62%847830556.431-62%
Usd Price Per Share1.880-13%2.1302.468-14%6.570-68%5.612-62%5.612-62%
Usd Profit---29701000.000-30304000.000+2%-59629500.000+101%-41877000.000+41%-41877000.000+41%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.148-0.157+7%-0.074-50%0.161-191%0.161-191%
 EOD+3 -5MRQTTM+16 -14YOY+11 -195Y+15 -1510Y+15 -15

4.2. Fundamental Score

Let's check the fundamental score of Erasca Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.391
Price to Book Ratio (EOD)Between0-10.897
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than120.325
Current Ratio (MRQ)Greater than112.260
Debt to Asset Ratio (MRQ)Less than10.199
Debt to Equity Ratio (MRQ)Less than10.248
Return on Equity (MRQ)Greater than0.15-0.094
Return on Assets (MRQ)Greater than0.05-0.075
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Erasca Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.785
Ma 20Greater thanMa 502.046
Ma 50Greater thanMa 1002.102
Ma 100Greater thanMa 2001.990
OpenGreater thanClose1.950
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -1,041527-514-279-793218-57565277



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets395,297
Total Liabilities78,611
Total Stockholder Equity316,686
 As reported
Total Liabilities 78,611
Total Stockholder Equity+ 316,686
Total Assets = 395,297

Assets

Total Assets395,297
Total Current Assets320,676
Long-term Assets74,621
Total Current Assets
Cash And Cash Equivalents 93,075
Short-term Investments 219,275
Other Current Assets 8,326
Total Current Assets  (as reported)320,676
Total Current Assets  (calculated)320,676
+/-0
Long-term Assets
Property Plant Equipment 60,188
Long Term Investments 9,642
Long-term Assets Other 4,383
Long-term Assets  (as reported)74,621
Long-term Assets  (calculated)74,213
+/- 408

Liabilities & Shareholders' Equity

Total Current Liabilities26,156
Long-term Liabilities52,455
Total Stockholder Equity316,686
Total Current Liabilities
Short-term Debt 3,970
Accounts payable 2,000
Other Current Liabilities 20,186
Total Current Liabilities  (as reported)26,156
Total Current Liabilities  (calculated)26,156
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt51,889
Long-term Liabilities Other 566
Long-term Liabilities  (as reported)52,455
Long-term Liabilities  (calculated)52,455
+/-0
Total Stockholder Equity
Common Stock15
Retained Earnings -606,013
Accumulated Other Comprehensive Income 77
Other Stockholders Equity 922,607
Total Stockholder Equity (as reported)316,686
Total Stockholder Equity (calculated)316,686
+/-0
Other
Capital Stock15
Cash and Short Term Investments 312,350
Common Stock Shares Outstanding 150,732
Liabilities and Stockholders Equity 395,297
Net Debt -37,216
Net Invested Capital 316,686
Net Working Capital 294,520
Property Plant and Equipment Gross 67,420
Short Long Term Debt Total 55,859



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
124,825
224,628
210,383
521,948
501,415
475,469
444,823
446,429
514,909
467,542
440,662
419,406
395,297
395,297419,406440,662467,542514,909446,429444,823475,469501,415521,948210,383224,628124,825000
   > Total Current Assets 
0
0
0
119,990
214,344
197,291
492,313
420,017
403,374
381,421
365,751
444,496
397,883
323,851
305,966
320,676
320,676305,966323,851397,883444,496365,751381,421403,374420,017492,313197,291214,344119,990000
       Cash And Cash Equivalents 
0
0
0
65,376
169,989
156,396
445,811
360,487
333,347
298,007
219,260
284,217
272,756
138,787
112,862
93,075
93,075112,862138,787272,756284,217219,260298,007333,347360,487445,811156,396169,98965,376000
       Short-term Investments 
0
0
0
53,325
42,351
37,277
40,834
53,988
59,186
73,469
136,668
151,403
116,985
178,458
183,806
219,275
219,275183,806178,458116,985151,403136,66873,46959,18653,98840,83437,27742,35153,325000
       Net Receivables 
0
0
0
0
0
0
0
100
0
100
100
0
1,000
1,325
926
0
09261,3251,000010010001000000000
       Other Current Assets 
0
0
0
1,289
2,004
3,618
5,668
5,542
10,841
9,945
9,823
8,876
8,142
6,606
9,298
8,326
8,3269,2986,6068,1428,8769,8239,94510,8415,5425,6683,6182,0041,289000
   > Long-term Assets 
0
0
0
4,835
10,284
13,092
29,635
81,398
72,095
63,402
80,678
70,413
69,659
116,811
113,440
74,621
74,621113,440116,81169,65970,41380,67863,40272,09581,39829,63513,09210,2844,835000
       Property Plant Equipment 
0
0
0
4,072
3,799
4,134
27,562
33,310
37,337
38,969
65,926
65,233
64,415
63,076
61,753
60,188
60,18861,75363,07664,41565,23365,92638,96937,33733,31027,5624,1343,7994,072000
       Long Term Investments 
0
0
0
0
5,000
5,000
0
44,770
29,224
19,313
9,569
0
0
48,079
46,891
9,642
9,64246,89148,079009,56919,31329,22444,77005,0005,0000000
       Other Assets 
0
0
0
0
1,485
3,958
2,073
53,630
5,534
5,120
446,429
5,180
3,244
3,656
0
0
003,6563,2445,180446,4295,1205,53453,6302,0733,9581,4850000
> Total Liabilities 
0
0
0
238,809
353,887
360,380
38,957
44,887
50,807
49,756
81,110
103,056
81,090
77,957
80,431
78,611
78,61180,43177,95781,090103,05681,11049,75650,80744,88738,957360,380353,887238,809000
   > Total Current Liabilities 
0
0
0
13,680
11,214
17,914
19,588
26,381
21,391
22,319
27,679
48,690
25,523
23,292
26,730
26,156
26,15626,73023,29225,52348,69027,67922,31921,39126,38119,58817,91411,21413,680000
       Short-term Debt 
0
0
0
877
898
888
864
285
14
201
1,028
1,305
3,118
3,670
3,818
3,970
3,9703,8183,6703,1181,3051,02820114285864888898877000
       Accounts payable 
0
0
0
878
1,042
1,507
1,324
4,677
4,712
2,291
4,319
23,049
3,353
2,631
3,701
2,000
2,0003,7012,6313,35323,0494,3192,2914,7124,6771,3241,5071,042878000
       Other Current Liabilities 
0
0
0
2,526
3,402
3,230
3,057
2,884
16,665
19,827
22,332
24,336
19,052
800
632
20,186
20,18663280019,05224,33622,33219,82716,6652,8843,0573,2303,4022,526000
   > Long-term Liabilities 
0
0
0
225,129
342,673
342,466
19,369
18,506
29,416
27,437
53,431
54,366
55,567
54,665
53,701
52,455
52,45553,70154,66555,56754,36653,43127,43729,41618,50619,369342,466342,673225,129000
       Warrants
0
0
0
0
0
340,798
0
0
0
0
0
0
0
0
0
0
0000000000340,79800000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
573
630
697
0
0
0069763057300000000000
       Deferred Long Term Liability 
0
0
0
0
183
0
0
0
0
0
0
0
0
0
0
0
000000000001830000
> Total Stockholder Equity
0
0
0
-113,984
-129,259
-149,997
482,991
456,528
424,662
395,067
-345,721
-480,971
-514,170
362,705
-576,312
316,686
316,686-576,312362,705-514,170-480,971-345,721395,067424,662456,528482,991-149,997-129,259-113,984000
   Common Stock
0
0
0
3
3
3
12
12
12
12
12
15
15
15
15
15
15151515151212121212333000
   Retained Earnings Total Equity00-545,951-514,170-480,971-345,721-310,232-274,624-238,166-207,702-161,63300000
   Accumulated Other Comprehensive Income 
0
0
0
2
1
-1
-521,948
-162
-951
-1,223
-1,379
-1,041
-514
-793
-575
77
77-575-793-514-1,041-1,379-1,223-951-162-521,948-112000
   Capital Surplus 
0
0
0
0
0
11,634
690,681
694,844
700,225
706,510
712,407
893,850
901,121
909,434
0
0
00909,434901,121893,850712,407706,510700,225694,844690,68111,63400000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
1,413
4,156
-329,164
690,681
694,844
700,225
706,510
1,367
1,026
499
909,434
560
922,607
922,607560909,4344991,0261,367706,510700,225694,844690,681-329,1644,1561,413000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-3,732
Gross Profit-3,732-3,732
 
Operating Income (+$)
Gross Profit-3,732
Operating Expense-137,793
Operating Income-141,525-141,525
 
Operating Expense (+$)
Research Development103,821
Selling General Administrative37,704
Selling And Marketing Expenses-3,732
Operating Expense137,793137,793
 
Net Interest Income (+$)
Interest Income15,352
Interest Expense-0
Other Finance Cost-0
Net Interest Income15,352
 
Pretax Income (+$)
Operating Income-141,525
Net Interest Income15,352
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-125,042-158,008
EBIT - interestExpense = -141,525
-125,042
-125,042
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-141,525-125,042
Earnings Before Interest and Taxes (EBITDA)-137,793
 
After tax Income (+$)
Income Before Tax-125,042
Tax Provision-0
Net Income From Continuing Ops-230,591-125,042
Net Income-125,042
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses141,525
Total Other Income/Expenses Net16,483-15,352
 

Technical Analysis of Erasca
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Erasca. The general trend of Erasca is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Erasca's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Erasca Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.96 < 2.44 < 2.45.

The bearish price targets are: 1.66 > 1.64 > 1.64.

Tweet this
Erasca Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Erasca Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Erasca Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Erasca Inc. The current macd is -0.07025541.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Erasca price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Erasca. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Erasca price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Erasca Inc Daily Moving Average Convergence/Divergence (MACD) ChartErasca Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Erasca Inc. The current adx is 18.81.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Erasca shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Erasca Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Erasca Inc. The current sar is 2.25509878.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Erasca Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Erasca Inc. The current rsi is 41.79. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Erasca Inc Daily Relative Strength Index (RSI) ChartErasca Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Erasca Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Erasca price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Erasca Inc Daily Stochastic Oscillator ChartErasca Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Erasca Inc. The current cci is -79.20749269.

Erasca Inc Daily Commodity Channel Index (CCI) ChartErasca Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Erasca Inc. The current cmo is -20.22619813.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Erasca Inc Daily Chande Momentum Oscillator (CMO) ChartErasca Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Erasca Inc. The current willr is -80.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Erasca is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Erasca Inc Daily Williams %R ChartErasca Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Erasca Inc.

Erasca Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Erasca Inc. The current atr is 0.14743721.

Erasca Inc Daily Average True Range (ATR) ChartErasca Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Erasca Inc. The current obv is -32,484,124.

Erasca Inc Daily On-Balance Volume (OBV) ChartErasca Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Erasca Inc. The current mfi is 39.81.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Erasca Inc Daily Money Flow Index (MFI) ChartErasca Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Erasca Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Erasca Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Erasca Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.785
Ma 20Greater thanMa 502.046
Ma 50Greater thanMa 1002.102
Ma 100Greater thanMa 2001.990
OpenGreater thanClose1.950
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Erasca with someone you think should read this too:
  • Are you bullish or bearish on Erasca? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Erasca? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Erasca Inc

I send you an email if I find something interesting about Erasca Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Erasca Inc.

Receive notifications about Erasca Inc in your mailbox!